Home About Us Pipeline Investors News & Events Careers Contact Us
S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values
Clinical Trials | R&D Programmes | Technologies & Capabilities | S*BIO’s Functional Capabilities | Publications
Investors | Partnerships
News & Press Releases | Participation in Events
Join Our Team | Job Openings | How to Apply

The best scientist is open to experience and begins with romance - the idea that anything is possible.
Ray Bradbury



Participation in Events


S*BIO participates in various international events and scientific conferences.

Date
Event
Dec 2007 The American Society of Hematology 49th Annual Meeting and Exposition
S*BIO will be delivering an oral presentation as well as presenting two posters at the American Society of Hematology 49th Annual Meeting and Exposition. The oral presentation is entitled "SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders" and the two posters are entitled “SB939: A Potent and Orally Active HDAC Inhibitor for the Treatment of Hematological Malignancies” (Poster # 757) and “SB1317: A Potent and Orally Active FLT3-CDK Inhibitor with High Anti-Tumor Efficacy in Models of Hematological Malignancies”(Poster # 747) respectively.

Oral Presentation:
Venue:


Poster Presentations:
Poster #:
Venue:
Monday, December 10, 2007, 2:15 PM
Room B213, Georgia World Congress Center
Atlanta, Georgia

Saturday, December 8 , 2007, 9:00 AM to 7:30PM
747 and 757
Hall B3, Georgia World Congress Center
Atlanta, Georgia


Nov 2007 IBD Think Tank Meeting
Dr. Jeanette Wood, Head of Biology at S*BIO, will present at the IBD Think-Tank Meeting at the Karolinska Institute. Her presentation is entitled "Inflammation and HDACs"

Presentation:
Venue:
Wednesday, November 14, 2007, 4:30 PM
Nobel Forum, Nobels väg 1, Karolinska Institutet, Stockholm


Nov 2007 Bio-Europe 13th Annual International Partnering Conference
Dr. Stephen Keith Rhind, Senior Vice President, Corporate Development of S*BIO, will present at the Bio-Europe 13th Annual International Partnering Conference. The presentation will introduce S*BIO and highlight the significant progress made in its HDAC and JAK2 kinase programs.

Presentation:
Venue:
Tuesday, November 13, 2007, 4:45PM
Room B2, Level 1, Congress Centre Hamburg, Germany


Nov 2007 Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Dr. Jan-Anders Karlsson, CEO of S*BIO, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The presentation will introduce S*BIO and highlight the significant progress made in its HDAC and JAK2 kinase programs.

Presentation:
Venue:
Wednesday, November 7, 2007, 2:20 PM
Kennedy 1 (4th Floor), New York Palace Hotel, New York, USA


Nov 2007 2007 AACR Centennial Conference on Translational Cancer Medicine
S*BIO will be presenting two posters at the 2007 AACR Centennial Conference on Translational Cancer Medicine in Singapore. The posters are entitled "Dot1L mediated histone H3-(Lys 79) methylation activates the p21Waf1 gene and functions as a biomarker for apoptotic sensitivity towards HDAC inhibitors" and "SB939: a potent, orally-active HDAC inhibitor for the treatment of haematologic malignancies and solid tumors" respectively.

Poster Presentation:
Poster #:
Venue:


Poster Presentation:
Poster #:
Venue:
Monday, November 5, 2007, 11:30 AM
A33
Ballroom 1, Level 2, Suntec Singapore Convention Centre

Wednesday, November 7, 2007, 11:30 AM
C14
Ballroom 1, Level 2, Suntec Singapore Convention Centre


Oct 2007 AACR-NCI-EORTC Conference on Molecular Targets
S*BIO will be presenting a poster at the upcoming AACR-NCI-EORTC Symposium on "Molecular Targets and Cancer Therapeutics" in San Francisco, USA. The poster is entitled "SB939: a potent and orally active HDAC inhibitor for the treatment of colorectal cancer".

Poster Presentation:
Poster #:
Venue:
Wednesday, October 24, 2007, 12:30 PM
B292
The Moscone Center, San Francisco, USA


Oct 2007 Bio Investor Forum
Dr. Jan-Anders Karlsson, CEO of S*BIO, will present at the Bio Investor Forum 2007. The presentation will introduce S*BIO and highlight the significant progress made in its HDAC and JAK2 kinase programs.

Presentation:
Venue:
Thursday, October 11, 2007, 11:00 AM
Napa Room, Palace Hotel, San Francisco, USA


Please click here for live audio Webcast of the presentation Thursday, 11 October 2007 at 11:00am PST. A replay of the Webcast will be available online for 90 days.


Oct 2007 8th International ISSX Meeting
S*BIO will be presenting a poster at the upcoming 8th International ISSX Meeting . The poster is entitled "Development of generic LC-MS-MS cocktail analysis method for the characterization of both cytochrome P450 inhibition and phenotyping properties of new chemical entities (NCEs) using Qtrap 3200 system".

Poster Presentation:
Poster #:
Venue:
Wednesday, October 10, 2007, 9:00 AM
Poster Session 1, Abstract #74
Sendai International Centre, Sendai, Japan


Oct 2007 ACS-EFMC 2007
S*BIO will be presenting an oral and a poster presentation at the upcoming ACS-EFMC Meeting in Siena, Italy. The abstract entitled "Indazoles as potent and selective aurora kinase inhibitors'' will highlight the synthesis, SAR and biological profiles of Indazole series.

Poster Presentation:
Poster #:
Venue:

Oral Presentation:
Abstract #:
Venue:
Sunday, October 6 , 2007 , 7:00PM
P39
Santa Maria della Scala - Conference Hall, Siena, Italy

Monday, October 7, 2007 , 12:20PM
P39
Santa Maria della Scalla - Conference Hall, Siena, Italy

Oct 2007 66th Annual Meeting of Japanese Cancer Association
Dr Jeanette Wood, Head of Biology, S*BIO Pte Ltd, will co-chair the session on targeted therapies and make a presentation highlighting SBIO progress with its lead clinical HDAC program at the 66th Annual Meeting of Japanese Cancer Association.

Presentation:
Venue:
Friday, October 5, 2007. 1:30 PM
Venue: Room E, Pacifico Yokohama


Oct 2007 CHI's Fifth Annual Protein Kinase Targets
S*BIO will be presenting a poster presentation at the upcoming CHI's Fifth Annual Protein Kinase Targets conference in Bonston, MA. The abstract entitled ¡°Indazoles as Potent and Selective Aurora Inhibitors¡± will highlight the the synthesis, SAR and biological profiles of Indazole series.

Post Presentation:
Poster#:
Venue:
Monday, June 4, 2007, 10:05AM
22
Harborview Ballroom, World Trade Center, Boston MA


Sep 2007 Rosenön Meeting 2007 : DMPK and PK/PD from Lead to Product - Recent Developments and Trends in an Expanding Science
S*BIO will be presenting a poster at the upcoming Rosenön Meeting 2007. The poster is entitled " Pharmacokinetic-pharmacodynamic (PK-PD) relationship of novel HDAC inhibitors in HCT116 mouse xenograft tumor model ".

Poster Presentation:
Poster #:
Venue:
Thursday, September 20, 4:50 PM
Nil
Rosenön, Stockholm, Sweden


Sep 2007 Drug Discovery in 21st Century
Dr. Jan-Anders Karlsson, CEO of S*BIO, will present at the Drug Discovery in 21st Century: Joint UK-Singapore Symposium. His presentation is entitled "Discovery and development of the HDAC inhibitor SB939 and other targeted anti-cancer agents in Singapore”.

Presentation:
Venue:
Tuesday, September 18, 2007, 2:30 PM
Breakthrough (Level 4), Matrix Building @ Biopolis, Singapore


June 2007 Drug Development Asia Summit 2007
Dr. Kantharaj Ethirajulu, Head of Preclinical Development at S*BIO, will present at the Drug Development Asia Summit 2007. His presentation is entitled " Experiences at S*BIO - Singapore's First, Oncology Focused, Integrated Drug Discovery and Development Company"

Presentation:
Venue:
Thursday, June 14, 2007, 09:00 AM
Taurus Room, Marina Mandarin Resort, Singapore


May 2007 BIO2007 Annual International Convention
Dr. Yin Chin Hew, Associate Director, Corporate Development of S*BIO, will present at the BIO2007 Annual International Convention. The presentation will introduce S*BIO and highlight the significant progress made in its HDAC and kinase programs.

Presentation:
Venue:
Wednesday, May 9, 2007, 10:15 AM EST
Room C in the Business Forum at the BIO International Convention 2007


S*BIO also invites all to visit its exhibition booth at the Singapore Pavilion (Booth 2533) located in the BIO2007 Exhibit Hall.

Mar 2007 Modern Trends in Healthcare
Dr Anders Poulsen, Lab Head of Computational Chemistry and Drug Discovery Informatics, is one of the 10 invited speakers participating in this workshop. He will give a presentation entitled "Virtual Screening".

Presentation:
Venue:
Tuesday, March 27, 2007, 2:00 PM
Creation (Level 4), Matrix Building @ Biopolis

Events Archive
2006 Events
2005 Events
2004 Events
2003 Events
2002 Events


Back to top



Copyright © 2002 S*BIO Pte Ltd. All rights reserved.